Erectile Dysfunction Market, By Application, By Therapy Type, By Product Type, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

Erectile Dysfunction Market size was valued at US$ 2,567.87 Million in 2024, expanding at a CAGR of 8.2% from 2025 to 2032.

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It is a multifactorial condition resulting from vascular, neurological, hormonal, or psychological causes that has a significant impact on men's physical and emotional health. The rising global prevalence of chronic diseases such as cardiovascular disorders and diabetes, both of which contribute significantly to ED, as well as sedentary lifestyles and stress-related conditions, is a key market driver. In contrast, the market is restrained by the loss of patent protection for blockbuster drugs such as Viagra and Cialis, which has resulted in price erosion and intense competition from generics. Nonetheless, an emerging opportunity is the development of next-generation oral therapies, stem-cell-based treatments, and digital health platforms that provide confidential online consultations and prescriptions. These innovations, combined with a growing acceptance of sexual wellness as part of men's health, are expected to drive the erectile dysfunction market's long-term growth and modernization.

Erectile Dysfunction Market- Market Dynamics

Rising Prevalence of Lifestyle-Related Diseases To Propel Growth In The Market

The increasing prevalence of lifestyle-related diseases is expected to fuel the erectile dysfunction market. Lifestyle-related diseases are health conditions that are primarily caused by unhealthy habits such as poor diet, lack of exercise, smoking, and binge drinking. The rise in lifestyle-related diseases is attributed to increased sedentary behavior, poor dietary habits, stress, and unhealthy habits such as smoking and excessive alcohol consumption. Erectile dysfunction (ED) is an early warning sign for lifestyle-related diseases such as cardiovascular disease and diabetes, emphasizing the importance of prompt medical attention and healthier lifestyle choices. For instance, according to a report published in May 2022 by the World Obesity Federation, a non-profit organization based in the United Kingdom, by 2030, one billion people worldwide, including one in every five women and one in every seven men, are expected to be obese, rising to 4 billion people, or 51% of the global population, by 2035. As a result, the increasing prevalence of lifestyle-related diseases will drive growth in the erectile dysfunction industry.

Erectile Dysfunction Market- Segmentation Analysis:

The Global Erectile Dysfunction Market is segmented by Application, Therapy Type, Product Type, Distribution Channel and Region.

According to the Application, Oral medication is the highest revenue-generating segment in the global erectile dysfunction drugs market in 2025, owing to an increase in the use of oral medications such as Cialis, Stendra, Viagra, and others, which can be self-administered and are cost-effective, as well as increasing partnerships and collaborations among market players. For instance, in May 2022, Laboratorios Rubio S.A. sold the prescription medication BANDOL (sildenafil oral suspension) to Aspargo Laboratories, Inc. BANDOL is used to treat erectile dysfunction. Concurrently with this acquisition, Aspargo signed a distribution agreement with Rubio to continue marketing and promoting BANDOL in the Spanish market.

By Distribution Channel, Online pharmacies are the most important selling channel in the global erectile dysfunction drugs market, owing to the rising incidence of erectile dysfunction, which is driving the adoption of alternative treatments for faster and more effective results, as well as the increased launch of advanced platforms. For example, in October 2023, Mangoceuticals, Inc., a company dedicated to the development, marketing, and sale of a range of men's health and wellness products through a secure telemedicine platform, including its specially formulated erectile dysfunction (ED) medication under the brand name "Mango," will launch its affiliate marketing program via its newly revamped website.

Erectile Dysfunction Market- Geographical Insights

North America is a significant revenue-generating region in the erectile dysfunction (ED) drugs market, thanks to a high prevalence of ED, advanced healthcare infrastructure, and widespread patient education. The region benefits from strong R&D capabilities as well as the presence of leading pharmaceutical companies like Pfizer Inc. (Viagra) and Eli Lilly and Company (Cialis), which are constantly innovating through novel formulations and combination therapies. High disposable incomes, improved access to healthcare, and favorable reimbursement frameworks all contribute to long-term market demand. However, patent expirations and the increasing availability of generic alternatives have increased competition and influenced pricing strategies. According to Oxford Academic (February 2024), the average ED prevalence rate in North America was 20.7%, with a steady increase observed across age groups and among individuals with associated health comorbidities, highlighting the region's continued clinical and commercial importance.

United States Erectile Dysfunction Market- Country Insights

The United States makes a significant contribution to the North American erectile dysfunction drug market. A large aging population, lifestyle-related diseases such as diabetes and hypertension, and rising awareness of erectile dysfunction treatment options all contribute to market growth. Pharmaceutical companies such as Pfizer and Eli Lilly have a significant presence, providing medications such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) through a variety of distribution channels, including retail pharmacies and online platforms. For example, in July 2023, Haleon entered the US OTC erectile dysfunction market with a commercialization agreement for Futura's drug-free MED3000 gel, which was recently approved by the FDA as a de novo medical device. Futura's topical treatment, which was recently approved by the US Food and Drug Administration as an over-the-counter medical device, cost $4 million to commercialize initially.

Erectile Dysfunction Market- Competitive Landscape:

Pfizer Inc., Eli Lilly and Company, Bayer AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., and Boston Scientific Corporation are among the top Erectile Dysfunction (ED) market players. These companies are actively diversifying their product offerings with innovations in oral medications, penile implants, and emerging regenerative therapies like stem cell and shockwave treatments. The market is experiencing increased competition as patents for blockbuster drugs such as Viagra and Cialis expire, allowing generics and biosimilars to enter the marketplace. In addition, strategic collaborations, mergers, and digital health integrations such as telemedicine platforms for prescription and consultation are influencing competitive dynamics. To meet the needs of a growing global patient base, the landscape prioritizes innovation, accessibility, and personalized treatment options. For instance, in February 2024, Petros Pharmaceuticals and 23andMe collaborated with a major AI software provider to incorporate advanced technology into its Self-Selection Study for STENDRA (avanafil) OTC approval. The AI-driven tool aimed to improve screening accuracy, ensure safe medication access in accordance with FDA and ACNU guidelines, and accelerate Petros' path to OTC status.

Recent Developments:

In March 2024, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI, a single-tablet combination of macitentan, an endothelin receptor antagonist (ERA), and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, for the chronic treatment of adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group I) and WHO functional class II-III.1 OPSYNVI(R) can be used for PAH patients who are treatment-naive or already taking an ERA, PDE5 inhibitor, or both.

In July 2024, Aspargo Labs, Inc., a speciality pharmaceutical and MedTech company focused on transforming drug delivery through innovative oral sprays, today announced the release of a Phase 1 study demonstrating that ASP-001, an investigative sildenafil oral spray in development for erectile dysfunction (ED), achieves absorption within five minutes, which is twice as fast as traditional sildenafil tablets.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL ERECTILE DYSFUNCTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bayer AG
Lilly
Petros Pharmaceuticals, Inc.
Pfizer Inc.
GlaxoSmithKline PLC
Teva Pharmaceutical
Sanofi
Industries Ltd
Lupin Limited
Futura Medical
Cure Pharmaceutical
Sun Pharmaceutical Industries Ltd
VIVUS, Inc.
Auxilium Pharmaceuticals, Inc.
Others

GLOBAL ERECTILE DYSFUNCTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Parenteral
Oral

GLOBAL ERECTILE DYSFUNCTION MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

Drug Therapy
Device Therapy

GLOBAL ERECTILE DYSFUNCTION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Generic Drugs
Sildenafil
Vardenafil
Alprostadil
Tadalafil
Others
Branded Drugs
Cialis
Zydena
Viagra
Others

GLOBAL ERECTILE DYSFUNCTION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

GLOBAL ERECTILE DYSFUNCTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5766

1. Erectile Dysfunction Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Erectile Dysfunction Market Snippet by Application
- 2.1.2. Erectile Dysfunction Market Snippet by Therapy Type
- 2.1.3. Erectile Dysfunction Market Snippet by Product Type
- 2.1.4. Erectile Dysfunction Market Snippet by Distribution Channel
- 2.1.5. Erectile Dysfunction Market Snippet by Country
- 2.1.6. Erectile Dysfunction Market Snippet by Region
2.2. Competitive Insights

3. Erectile Dysfunction Key Market Trends

3.1. Erectile Dysfunction Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Erectile Dysfunction Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Erectile Dysfunction Market Opportunities
3.4. Erectile Dysfunction Market Future Trends

4. Erectile Dysfunction Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Erectile Dysfunction Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Erectile Dysfunction Market Landscape

6.1. Erectile Dysfunction Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Erectile Dysfunction Market - By Application

7.1. Overview
- 7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 7.1.2. Parenteral
- 7.1.3. Oral

8. Erectile Dysfunction Market - By Therapy Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
- 8.1.2. Drug Therapy
- 8.1.3. Device Therapy

9. Erectile Dysfunction Market - By Product Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 9.1.2. Generic Drugs
  - 9.1.2.1. Sildenafil
  - 9.1.2.2. Vardenafil
  - 9.1.2.3. Alprostadil
  - 9.1.2.4. Tadalafil
  - 9.1.2.5. Others
- 9.1.3. Branded Drugs
  - 9.1.3.1. Cialis
  - 9.1.3.2. Zydena
  - 9.1.3.3. Viagra
  - 9.1.3.4. Others

10. Erectile Dysfunction Market - By Distribution Channel

10.1. Overview
- 10.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
- 10.1.2. Hospital Pharmacies
- 10.1.3. Online Pharmacies
- 10.1.4. Retail Pharmacies

11. Erectile Dysfunction Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Erectile Dysfunction Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Erectile Dysfunction Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Erectile Dysfunction Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Erectile Dysfunction Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Erectile Dysfunction Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Erectile Dysfunction Industry

12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Bayer AG
- 12.2.2. Lilly
- 12.2.3. Petros Pharmaceuticals, Inc.
- 12.2.4. Pfizer Inc.
- 12.2.5. GlaxoSmithKline PLC
- 12.2.6. Teva Pharmaceutical
- 12.2.7. Sanofi
- 12.2.8. Industries Ltd
- 12.2.9. Lupin Limited
- 12.2.10. Futura Medical
- 12.2.11. Cure Pharmaceutical
- 12.2.12. Sun Pharmaceutical Industries Ltd
- 12.2.13. VIVUS, Inc.
- 12.2.14. Auxilium Pharmaceuticals, Inc.
- 12.2.15. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us